This fact sheet was prepared by the Iowa Office of Drug Control Policy (http://www.iowa.gov/odcp) for informational purposes only. ODCP does not dispense legal advice. Please seek legal counsel as warranted.
· The IMCA passed by the Legislature in April 2014 and signed into law by Governor Branstad May 30, 2014, is effective July 1, 2014. The Iowa Department of Public Health is currently developing administrative rules and an implementation plan for SF 2360.
· CBD, or cannabidiol, is defined in the IMCA as “a non-psychoactive cannabinoid found in the plant Cannabis sativa L. or Cannabis indica or any other preparation thereof that is essentially free from plant material, and has a tetrahydrocannabinol level of no more than three percent.” (Tetrahydrocannabinol, or THC is a psychoactive compound in cannabis.)
· CBD is often used as a solution. Contents may vary in color and consistency, and so too may packaging and oral/transdermal delivery systems.
· As a non-psychoactive extract of the cannabis plant with low potential for abuse, CBD is not marijuana or “medical marijuana,” as defined and sometimes discussed. Marijuana, with a high potential for abuse, remains prohibited in Iowa as a Schedule I Controlled Substance.
· There is evidence that CBD may provide relief to some severe seizure patients, such as those with Dravet or Lennox-Gastaut syndrome. A pharmaceutical CBD product is being tested for these conditions in clinical trials sanctioned by the U.S. Food and Drug Administration.
· A person who knowingly or intentionally possesses or uses CBD in violation of the IMCA is subject to criminal penalties under Iowa Code chapters 124 and 453B.
· The IMCA requires the University of Iowa to report annually to the Iowa Department of Public Health and Iowa Legislature on scientific studies of CBD and treatment efficacy.
· The IMCA is automatically repealed July 1, 2017.
The Iowa Department of Public Health is in the process of implementing the IMCA, and is developing administrative rules to provide additional guidance. The IMCA may be reviewed at: http://coolice.legis.iowa.gov/linc/85/external/SF2360_Enrolled.pdf. For additional information on the IMCA, please contact: Jill Myers-Geadelmann, Iowa Department of Public Health, Chronic Disease Prevention and Management Bureau by phone at 515-242-6067 or by email at Jill.Myers-Geadelmann@idph.iowa.gov
Learn more about who can obtain the CBD Oil next week in Part 2 of 2014 Iowa Medical Cannabidiol Act (IMCA, SF 2360) Quick Facts.